GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF6
|
ENSG00000067082.10 | Kruppel like factor 6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF6 | hg19_v2_chr10_-_3827371_3827386 | 0.32 | 1.2e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_151254738 | 88.98 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
chr2_+_203499901 | 66.41 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
chr14_-_21945057 | 60.08 |
ENST00000397762.1
|
RAB2B
|
RAB2B, member RAS oncogene family |
chr17_-_42277203 | 36.47 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr18_-_51750948 | 32.95 |
ENST00000583046.1
ENST00000398398.2 |
MBD2
|
methyl-CpG binding domain protein 2 |
chr1_+_156698234 | 28.51 |
ENST00000368218.4
ENST00000368216.4 |
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr19_+_16435625 | 28.34 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr11_+_57365150 | 28.00 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr1_-_182361327 | 26.45 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr1_+_156698708 | 26.33 |
ENST00000519086.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr1_-_182360918 | 26.30 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
chr20_-_35492048 | 25.54 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
chr1_-_182360498 | 24.59 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
chr3_+_49507674 | 22.64 |
ENST00000431960.1
ENST00000452317.1 ENST00000435508.2 ENST00000452060.1 ENST00000428779.1 ENST00000419218.1 ENST00000430636.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
chr10_+_76586348 | 22.50 |
ENST00000372724.1
ENST00000287239.4 ENST00000372714.1 |
KAT6B
|
K(lysine) acetyltransferase 6B |
chr12_+_53773944 | 22.26 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
chr15_+_74422585 | 20.52 |
ENST00000561740.1
ENST00000435464.1 ENST00000453268.2 |
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
chr1_-_113615699 | 19.28 |
ENST00000421157.1
|
RP11-31F15.2
|
RP11-31F15.2 |
chr6_-_33285505 | 17.51 |
ENST00000431845.2
|
ZBTB22
|
zinc finger and BTB domain containing 22 |
chr14_-_81687197 | 16.59 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr11_+_94706973 | 15.42 |
ENST00000536741.1
|
KDM4D
|
lysine (K)-specific demethylase 4D |
chr2_-_25475120 | 14.46 |
ENST00000380746.4
ENST00000402667.1 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr15_-_75744014 | 14.23 |
ENST00000394947.3
ENST00000565264.1 |
SIN3A
|
SIN3 transcription regulator family member A |
chr22_+_38004832 | 14.01 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr19_-_10764509 | 13.72 |
ENST00000591501.1
|
ILF3-AS1
|
ILF3 antisense RNA 1 (head to head) |
chr16_-_49315731 | 13.43 |
ENST00000219197.6
|
CBLN1
|
cerebellin 1 precursor |
chr14_-_81687575 | 13.27 |
ENST00000434192.2
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr2_+_70142232 | 13.17 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
chr7_-_72936608 | 13.10 |
ENST00000404251.1
|
BAZ1B
|
bromodomain adjacent to zinc finger domain, 1B |
chr3_+_38495333 | 12.86 |
ENST00000352511.4
|
ACVR2B
|
activin A receptor, type IIB |
chr22_+_41777927 | 12.67 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
chr19_+_8455200 | 12.51 |
ENST00000601897.1
ENST00000594216.1 |
RAB11B
|
RAB11B, member RAS oncogene family |
chr2_+_70142189 | 12.48 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr6_+_72596604 | 12.47 |
ENST00000348717.5
ENST00000517960.1 ENST00000518273.1 ENST00000522291.1 ENST00000521978.1 ENST00000520567.1 ENST00000264839.7 |
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr1_-_236445251 | 12.46 |
ENST00000354619.5
ENST00000327333.8 |
ERO1LB
|
ERO1-like beta (S. cerevisiae) |
chr10_-_124768300 | 12.17 |
ENST00000368886.5
|
IKZF5
|
IKAROS family zinc finger 5 (Pegasus) |
chr18_-_72265035 | 12.13 |
ENST00000585279.1
ENST00000580048.1 |
LINC00909
|
long intergenic non-protein coding RNA 909 |
chr11_+_68228186 | 11.98 |
ENST00000393799.2
ENST00000393800.2 ENST00000528635.1 ENST00000533127.1 ENST00000529907.1 ENST00000529344.1 ENST00000534534.1 ENST00000524845.1 ENST00000265637.4 ENST00000524904.1 ENST00000393801.3 ENST00000265636.5 ENST00000529710.1 |
PPP6R3
|
protein phosphatase 6, regulatory subunit 3 |
chr11_-_2160180 | 11.71 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr8_-_125486755 | 11.57 |
ENST00000499418.2
ENST00000530778.1 |
RNF139-AS1
|
RNF139 antisense RNA 1 (head to head) |
chr5_+_137801160 | 11.56 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr11_+_94706804 | 11.16 |
ENST00000335080.5
|
KDM4D
|
lysine (K)-specific demethylase 4D |
chr10_+_102672712 | 11.11 |
ENST00000370271.3
ENST00000370269.3 ENST00000609386.1 |
FAM178A
|
family with sequence similarity 178, member A |
chr17_-_27278304 | 11.06 |
ENST00000577226.1
|
PHF12
|
PHD finger protein 12 |
chr1_+_6845384 | 11.04 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr15_-_72410350 | 11.00 |
ENST00000356056.5
ENST00000424560.1 ENST00000444904.1 |
MYO9A
|
myosin IXA |
chr2_+_220283091 | 10.92 |
ENST00000373960.3
|
DES
|
desmin |
chr3_-_167813672 | 10.58 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
chr2_+_105471969 | 10.22 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr22_+_38004473 | 10.06 |
ENST00000414350.3
ENST00000343632.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr10_+_124768482 | 10.01 |
ENST00000368869.4
ENST00000358776.4 |
ACADSB
|
acyl-CoA dehydrogenase, short/branched chain |
chr14_-_50698276 | 10.00 |
ENST00000216373.5
|
SOS2
|
son of sevenless homolog 2 (Drosophila) |
chr17_+_36508111 | 9.93 |
ENST00000331159.5
ENST00000577233.1 |
SOCS7
|
suppressor of cytokine signaling 7 |
chr10_-_75634219 | 9.81 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr1_-_38512450 | 9.61 |
ENST00000373012.2
|
POU3F1
|
POU class 3 homeobox 1 |
chr3_-_167813132 | 9.48 |
ENST00000309027.4
|
GOLIM4
|
golgi integral membrane protein 4 |
chr11_+_117070037 | 9.41 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
chr4_-_76598326 | 9.15 |
ENST00000503660.1
|
G3BP2
|
GTPase activating protein (SH3 domain) binding protein 2 |
chr8_-_33424636 | 8.99 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
chr20_-_524362 | 8.93 |
ENST00000460062.2
ENST00000608066.1 |
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide |
chr7_-_143105941 | 8.92 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
chr17_-_42276574 | 8.88 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr19_-_5978144 | 8.76 |
ENST00000340578.6
ENST00000541471.1 ENST00000591736.1 ENST00000587479.1 |
RANBP3
|
RAN binding protein 3 |
chr2_-_30144432 | 8.43 |
ENST00000389048.3
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase |
chr19_-_5978090 | 8.22 |
ENST00000592621.1
ENST00000034275.8 ENST00000591092.1 ENST00000591333.1 ENST00000590623.1 ENST00000439268.2 ENST00000587159.1 |
RANBP3
|
RAN binding protein 3 |
chr10_+_104474207 | 8.19 |
ENST00000602831.1
ENST00000369893.5 |
SFXN2
|
sideroflexin 2 |
chr1_+_207226574 | 8.07 |
ENST00000367080.3
ENST00000367079.2 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
chr3_-_53080047 | 8.05 |
ENST00000482396.1
ENST00000358080.2 ENST00000296295.6 ENST00000394752.3 |
SFMBT1
|
Scm-like with four mbt domains 1 |
chr6_+_83777374 | 8.05 |
ENST00000349129.2
ENST00000237163.5 ENST00000536812.1 |
DOPEY1
|
dopey family member 1 |
chr15_-_75743991 | 7.84 |
ENST00000567289.1
|
SIN3A
|
SIN3 transcription regulator family member A |
chr4_-_174451370 | 7.80 |
ENST00000359562.4
|
HAND2
|
heart and neural crest derivatives expressed 2 |
chr3_-_50540854 | 7.70 |
ENST00000423994.2
ENST00000424201.2 ENST00000479441.1 ENST00000429770.1 |
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
chr11_-_3862059 | 7.68 |
ENST00000396978.1
|
RHOG
|
ras homolog family member G |
chr12_+_52445191 | 7.64 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr15_+_43803143 | 7.59 |
ENST00000382031.1
|
MAP1A
|
microtubule-associated protein 1A |
chr14_+_58765103 | 7.55 |
ENST00000355431.3
ENST00000348476.3 ENST00000395168.3 |
ARID4A
|
AT rich interactive domain 4A (RBP1-like) |
chr6_+_37137939 | 7.53 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr11_+_45868957 | 7.52 |
ENST00000443527.2
|
CRY2
|
cryptochrome 2 (photolyase-like) |
chr2_+_219433281 | 7.41 |
ENST00000273064.6
ENST00000509807.2 ENST00000542068.1 |
RQCD1
|
RCD1 required for cell differentiation1 homolog (S. pombe) |
chr11_-_62521614 | 7.37 |
ENST00000527994.1
ENST00000394807.3 |
ZBTB3
|
zinc finger and BTB domain containing 3 |
chr9_+_35605274 | 7.30 |
ENST00000336395.5
|
TESK1
|
testis-specific kinase 1 |
chr11_-_133826852 | 7.29 |
ENST00000533871.2
ENST00000321016.8 |
IGSF9B
|
immunoglobulin superfamily, member 9B |
chr19_+_54372639 | 7.27 |
ENST00000391769.2
|
MYADM
|
myeloid-associated differentiation marker |
chr2_-_71454185 | 7.20 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr12_+_10365404 | 7.14 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr10_-_101380121 | 7.08 |
ENST00000370495.4
|
SLC25A28
|
solute carrier family 25 (mitochondrial iron transporter), member 28 |
chr17_-_74449252 | 7.04 |
ENST00000319380.7
|
UBE2O
|
ubiquitin-conjugating enzyme E2O |
chr19_-_46000251 | 7.00 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
chr5_-_159739532 | 6.75 |
ENST00000520748.1
ENST00000393977.3 ENST00000257536.7 |
CCNJL
|
cyclin J-like |
chr5_+_34929677 | 6.75 |
ENST00000342382.4
ENST00000382021.2 ENST00000303525.7 |
DNAJC21
|
DnaJ (Hsp40) homolog, subfamily C, member 21 |
chr22_+_38005033 | 6.74 |
ENST00000447515.1
ENST00000406772.1 ENST00000431745.1 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr6_-_31125850 | 6.67 |
ENST00000507751.1
ENST00000448162.2 ENST00000502557.1 ENST00000503420.1 ENST00000507892.1 ENST00000507226.1 ENST00000513222.1 ENST00000503934.1 ENST00000396263.2 ENST00000508683.1 ENST00000428174.1 ENST00000448141.2 ENST00000507829.1 ENST00000455279.2 ENST00000376266.5 |
CCHCR1
|
coiled-coil alpha-helical rod protein 1 |
chr17_+_73452695 | 6.66 |
ENST00000582186.1
ENST00000582455.1 ENST00000581252.1 ENST00000579208.1 |
KIAA0195
|
KIAA0195 |
chrX_+_48660287 | 6.62 |
ENST00000444343.2
ENST00000376610.2 ENST00000334136.5 ENST00000376619.2 |
HDAC6
|
histone deacetylase 6 |
chr9_+_34989638 | 6.59 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr12_+_70132632 | 6.56 |
ENST00000378815.6
ENST00000483530.2 ENST00000325555.9 |
RAB3IP
|
RAB3A interacting protein |
chr12_-_7125770 | 6.56 |
ENST00000261407.4
|
LPCAT3
|
lysophosphatidylcholine acyltransferase 3 |
chr10_+_50818343 | 6.55 |
ENST00000374115.3
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3 |
chr11_-_119234876 | 6.48 |
ENST00000525735.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr2_+_111878483 | 6.45 |
ENST00000308659.8
ENST00000357757.2 ENST00000393253.2 ENST00000337565.5 ENST00000393256.3 |
BCL2L11
|
BCL2-like 11 (apoptosis facilitator) |
chr5_+_149109825 | 6.43 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
chr7_+_86781847 | 6.41 |
ENST00000432366.2
ENST00000423590.2 ENST00000394703.5 |
DMTF1
|
cyclin D binding myb-like transcription factor 1 |
chr11_-_62494821 | 6.36 |
ENST00000301785.5
|
HNRNPUL2
|
heterogeneous nuclear ribonucleoprotein U-like 2 |
chr14_-_82000140 | 6.36 |
ENST00000555824.1
ENST00000557372.1 ENST00000336735.4 |
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans) |
chr4_+_159593271 | 6.35 |
ENST00000512251.1
ENST00000511912.1 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
chr3_-_49907323 | 6.33 |
ENST00000296471.7
ENST00000488336.1 ENST00000467248.1 ENST00000466940.1 ENST00000463537.1 ENST00000480398.2 |
CAMKV
|
CaM kinase-like vesicle-associated |
chr19_-_14117074 | 6.31 |
ENST00000588885.1
ENST00000254325.4 |
RFX1
|
regulatory factor X, 1 (influences HLA class II expression) |
chr17_-_7120498 | 6.31 |
ENST00000485100.1
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr15_-_72410109 | 6.28 |
ENST00000564571.1
|
MYO9A
|
myosin IXA |
chr6_+_71122974 | 6.19 |
ENST00000418814.2
|
FAM135A
|
family with sequence similarity 135, member A |
chr12_+_57482665 | 6.19 |
ENST00000300131.3
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr7_+_86781677 | 6.18 |
ENST00000331242.7
ENST00000394702.3 ENST00000413276.2 ENST00000446796.2 ENST00000411766.2 ENST00000420131.1 ENST00000414630.2 ENST00000453049.1 ENST00000428819.1 ENST00000448598.1 ENST00000449088.3 ENST00000430405.3 |
DMTF1
|
cyclin D binding myb-like transcription factor 1 |
chr10_-_75634260 | 6.12 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr14_+_94640671 | 6.10 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr7_+_116593292 | 6.09 |
ENST00000393446.2
ENST00000265437.5 ENST00000393451.3 |
ST7
|
suppression of tumorigenicity 7 |
chr6_-_94129244 | 6.04 |
ENST00000369303.4
ENST00000369297.1 |
EPHA7
|
EPH receptor A7 |
chr10_+_99258625 | 6.02 |
ENST00000370664.3
|
UBTD1
|
ubiquitin domain containing 1 |
chr1_-_156698591 | 6.00 |
ENST00000368219.1
|
ISG20L2
|
interferon stimulated exonuclease gene 20kDa-like 2 |
chr3_+_50192537 | 5.98 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr14_-_92572894 | 5.98 |
ENST00000532032.1
ENST00000506466.1 ENST00000555381.1 ENST00000557311.1 ENST00000554592.1 ENST00000554672.1 ENST00000553491.1 ENST00000556220.1 ENST00000502250.1 ENST00000503767.1 ENST00000393287.5 ENST00000340660.6 ENST00000545170.1 ENST00000429774.2 |
ATXN3
|
ataxin 3 |
chr15_+_41136216 | 5.89 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr21_+_43639211 | 5.89 |
ENST00000450121.1
ENST00000398449.3 ENST00000361802.2 |
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr10_+_45869652 | 5.81 |
ENST00000542434.1
ENST00000374391.2 |
ALOX5
|
arachidonate 5-lipoxygenase |
chrX_-_49056635 | 5.79 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
chr2_+_61404624 | 5.78 |
ENST00000394457.3
|
AHSA2
|
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) |
chr19_+_10400615 | 5.78 |
ENST00000221980.4
|
ICAM5
|
intercellular adhesion molecule 5, telencephalin |
chr4_-_36246060 | 5.77 |
ENST00000303965.4
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr17_+_42264322 | 5.77 |
ENST00000446571.3
ENST00000357984.3 ENST00000538716.2 |
TMUB2
|
transmembrane and ubiquitin-like domain containing 2 |
chr19_+_54641444 | 5.76 |
ENST00000221232.5
ENST00000358389.3 |
CNOT3
|
CCR4-NOT transcription complex, subunit 3 |
chr17_-_36956155 | 5.69 |
ENST00000269554.3
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
chr14_+_94640633 | 5.67 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr3_+_49449636 | 5.67 |
ENST00000273590.3
|
TCTA
|
T-cell leukemia translocation altered |
chr7_+_96634850 | 5.66 |
ENST00000518156.2
|
DLX6
|
distal-less homeobox 6 |
chr13_+_28712614 | 5.66 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr22_+_32149927 | 5.63 |
ENST00000437411.1
ENST00000535622.1 ENST00000536766.1 ENST00000400242.3 ENST00000266091.3 ENST00000400249.2 ENST00000400246.1 ENST00000382105.2 |
DEPDC5
|
DEP domain containing 5 |
chr16_-_68482440 | 5.60 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
chr12_+_57610562 | 5.60 |
ENST00000349394.5
|
NXPH4
|
neurexophilin 4 |
chr5_-_134871639 | 5.58 |
ENST00000314744.4
|
NEUROG1
|
neurogenin 1 |
chr1_-_204121102 | 5.52 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
chr19_-_40791211 | 5.49 |
ENST00000579047.1
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
chr12_-_120554622 | 5.43 |
ENST00000229340.5
|
RAB35
|
RAB35, member RAS oncogene family |
chr19_+_36545833 | 5.41 |
ENST00000401500.2
ENST00000270301.7 ENST00000427823.2 |
WDR62
|
WD repeat domain 62 |
chr8_+_28196157 | 5.37 |
ENST00000522209.1
|
PNOC
|
prepronociceptin |
chr1_+_114522049 | 5.34 |
ENST00000369551.1
ENST00000320334.4 |
OLFML3
|
olfactomedin-like 3 |
chr19_-_15311713 | 5.31 |
ENST00000601011.1
ENST00000263388.2 |
NOTCH3
|
notch 3 |
chr10_+_112836779 | 5.31 |
ENST00000280155.2
|
ADRA2A
|
adrenoceptor alpha 2A |
chr5_+_56111361 | 5.30 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr2_+_64751433 | 5.26 |
ENST00000238856.4
ENST00000422803.1 ENST00000238855.7 |
AFTPH
|
aftiphilin |
chr15_+_41136586 | 5.25 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr15_-_53082178 | 5.22 |
ENST00000305901.5
|
ONECUT1
|
one cut homeobox 1 |
chr16_+_69600209 | 5.21 |
ENST00000566899.1
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive |
chr17_-_58469474 | 5.20 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
chr15_-_66084428 | 5.15 |
ENST00000443035.3
ENST00000431932.2 |
DENND4A
|
DENN/MADD domain containing 4A |
chr12_-_51611477 | 5.15 |
ENST00000389243.4
|
POU6F1
|
POU class 6 homeobox 1 |
chr4_+_155665123 | 5.14 |
ENST00000336356.3
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
chr17_+_61554413 | 5.14 |
ENST00000538928.1
ENST00000290866.4 ENST00000428043.1 |
ACE
|
angiotensin I converting enzyme |
chr17_+_42264395 | 5.14 |
ENST00000587989.1
ENST00000590235.1 |
TMUB2
|
transmembrane and ubiquitin-like domain containing 2 |
chr6_-_150039249 | 5.13 |
ENST00000543571.1
|
LATS1
|
large tumor suppressor kinase 1 |
chr16_+_67465016 | 5.11 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
chr15_-_83316254 | 5.11 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr17_+_42264556 | 5.11 |
ENST00000319511.6
ENST00000589785.1 ENST00000592825.1 ENST00000589184.1 |
TMUB2
|
transmembrane and ubiquitin-like domain containing 2 |
chr5_-_81046904 | 5.09 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
chr11_-_19262486 | 5.05 |
ENST00000250024.4
|
E2F8
|
E2F transcription factor 8 |
chr1_+_113615794 | 5.05 |
ENST00000361127.5
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2 |
chr20_-_35724388 | 5.04 |
ENST00000344359.3
ENST00000373664.3 |
RBL1
|
retinoblastoma-like 1 (p107) |
chr3_+_50192499 | 5.01 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr2_-_220408430 | 5.00 |
ENST00000243776.6
|
CHPF
|
chondroitin polymerizing factor |
chr1_+_21835858 | 4.96 |
ENST00000539907.1
ENST00000540617.1 ENST00000374840.3 |
ALPL
|
alkaline phosphatase, liver/bone/kidney |
chr2_+_219724544 | 4.94 |
ENST00000233948.3
|
WNT6
|
wingless-type MMTV integration site family, member 6 |
chr11_+_64851729 | 4.92 |
ENST00000526791.1
ENST00000526945.1 |
ZFPL1
|
zinc finger protein-like 1 |
chr14_-_65346555 | 4.87 |
ENST00000542895.1
ENST00000556626.1 |
SPTB
|
spectrin, beta, erythrocytic |
chr12_+_9067123 | 4.86 |
ENST00000543824.1
|
PHC1
|
polyhomeotic homolog 1 (Drosophila) |
chr4_+_6202448 | 4.85 |
ENST00000508601.1
|
RP11-586D19.1
|
RP11-586D19.1 |
chr17_-_1389228 | 4.84 |
ENST00000438665.2
|
MYO1C
|
myosin IC |
chr17_-_8066250 | 4.82 |
ENST00000488857.1
ENST00000481878.1 ENST00000316509.6 ENST00000498285.1 |
VAMP2
RP11-599B13.6
|
vesicle-associated membrane protein 2 (synaptobrevin 2) Uncharacterized protein |
chr9_-_37465396 | 4.81 |
ENST00000307750.4
|
ZBTB5
|
zinc finger and BTB domain containing 5 |
chr12_+_70760056 | 4.80 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr20_+_57875658 | 4.80 |
ENST00000371025.3
|
EDN3
|
endothelin 3 |
chr17_-_47841485 | 4.79 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chr4_-_153456153 | 4.68 |
ENST00000603548.1
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr19_+_42724423 | 4.65 |
ENST00000301215.3
ENST00000597945.1 |
ZNF526
|
zinc finger protein 526 |
chr1_-_113498616 | 4.64 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
chr3_-_184079382 | 4.63 |
ENST00000344937.7
ENST00000423355.2 ENST00000434054.2 ENST00000457512.1 ENST00000265593.4 |
CLCN2
|
chloride channel, voltage-sensitive 2 |
chrY_-_25345070 | 4.62 |
ENST00000382510.4
ENST00000426000.2 ENST00000540248.1 ENST00000405239.1 |
DAZ1
|
deleted in azoospermia 1 |
chr5_+_40679584 | 4.58 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr17_+_47572647 | 4.56 |
ENST00000172229.3
|
NGFR
|
nerve growth factor receptor |
chr7_+_106685079 | 4.53 |
ENST00000265717.4
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta |
chr6_+_35227449 | 4.47 |
ENST00000373953.3
ENST00000440666.2 ENST00000339411.5 |
ZNF76
|
zinc finger protein 76 |
chr3_-_135914615 | 4.46 |
ENST00000309993.2
|
MSL2
|
male-specific lethal 2 homolog (Drosophila) |
chr11_-_66445219 | 4.45 |
ENST00000525754.1
ENST00000531969.1 ENST00000524637.1 ENST00000531036.2 ENST00000310046.4 |
RBM4B
|
RNA binding motif protein 4B |
chr6_+_72596406 | 4.45 |
ENST00000491071.2
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr17_+_43299156 | 4.44 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
chr16_+_69600058 | 4.41 |
ENST00000393742.2
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive |
chr7_+_128828713 | 4.40 |
ENST00000249373.3
|
SMO
|
smoothened, frizzled family receptor |
chr2_-_114514181 | 4.39 |
ENST00000409342.1
|
SLC35F5
|
solute carrier family 35, member F5 |
chr9_+_100174344 | 4.38 |
ENST00000422139.2
|
TDRD7
|
tudor domain containing 7 |
chr3_-_170626418 | 4.36 |
ENST00000474096.1
ENST00000295822.2 |
EIF5A2
|
eukaryotic translation initiation factor 5A2 |
chr11_-_113345842 | 4.35 |
ENST00000346454.3
|
DRD2
|
dopamine receptor D2 |
chr1_+_160336851 | 4.35 |
ENST00000302101.5
|
NHLH1
|
nescient helix loop helix 1 |
chr5_-_148033726 | 4.33 |
ENST00000354217.2
ENST00000314512.6 ENST00000362016.2 |
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.3 | 77.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
11.6 | 11.6 | GO:0071505 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
9.4 | 28.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
7.4 | 22.1 | GO:0051595 | response to methylglyoxal(GO:0051595) |
5.3 | 26.6 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
4.4 | 22.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
4.1 | 24.6 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
3.3 | 16.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.2 | 6.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
3.1 | 12.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.7 | 54.8 | GO:0031167 | rRNA methylation(GO:0031167) |
2.6 | 40.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
2.5 | 7.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.4 | 17.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
2.4 | 7.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
2.3 | 11.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.2 | 6.6 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
2.2 | 28.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
2.1 | 8.4 | GO:0036269 | swimming behavior(GO:0036269) |
2.0 | 10.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
1.9 | 7.5 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
1.8 | 7.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.8 | 5.3 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.8 | 28.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.7 | 5.0 | GO:0071529 | cementum mineralization(GO:0071529) |
1.6 | 6.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
1.6 | 45.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.6 | 4.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.6 | 8.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.6 | 1.6 | GO:0035803 | egg coat formation(GO:0035803) |
1.5 | 7.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.5 | 4.6 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
1.5 | 6.0 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
1.5 | 5.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.5 | 10.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.5 | 11.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.4 | 14.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.4 | 5.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
1.4 | 4.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
1.4 | 6.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.4 | 11.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
1.4 | 9.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.3 | 24.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.3 | 3.9 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.3 | 5.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.3 | 2.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.3 | 3.9 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
1.3 | 5.1 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
1.3 | 3.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.3 | 7.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
1.2 | 3.7 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
1.2 | 2.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.2 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.2 | 12.9 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.2 | 4.7 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
1.2 | 3.5 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.2 | 4.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.1 | 4.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.1 | 4.4 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
1.1 | 4.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.1 | 4.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.0 | 19.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.0 | 5.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
1.0 | 9.2 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
1.0 | 8.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 3.0 | GO:0060592 | mammary gland formation(GO:0060592) |
1.0 | 3.0 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
1.0 | 3.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.0 | 3.0 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.0 | 3.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.9 | 4.7 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.9 | 6.5 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.9 | 6.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 5.5 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.9 | 4.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.9 | 7.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.9 | 4.5 | GO:0097338 | response to clozapine(GO:0097338) |
0.8 | 7.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.8 | 4.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.8 | 1.6 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 2.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.8 | 5.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.8 | 4.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.8 | 4.0 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.8 | 2.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.8 | 9.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.8 | 5.3 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.7 | 2.2 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.7 | 5.1 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.7 | 5.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 3.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 5.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.7 | 4.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 | 2.0 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.7 | 2.0 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.7 | 11.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 | 2.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 5.8 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.6 | 3.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 5.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.6 | 7.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.6 | 61.1 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.6 | 1.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.6 | 3.0 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.6 | 6.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) nephric duct morphogenesis(GO:0072178) |
0.6 | 4.7 | GO:0090166 | Golgi disassembly(GO:0090166) spindle assembly involved in meiosis(GO:0090306) |
0.6 | 5.8 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.6 | 4.0 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 5.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.5 | 4.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 17.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 22.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.5 | 7.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 1.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.5 | 2.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 1.6 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.5 | 7.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.5 | 1.5 | GO:0044805 | late nucleophagy(GO:0044805) |
0.5 | 3.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.5 | 10.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.5 | 5.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 4.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 1.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 3.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 1.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.3 | GO:1900158 | negative regulation of osteoclast proliferation(GO:0090291) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.4 | 2.7 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.4 | 3.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 11.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 2.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 6.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 5.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 6.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 3.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.4 | 2.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 4.3 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 2.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 5.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 4.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 28.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 2.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.4 | 7.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 2.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 8.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 4.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.3 | 3.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 9.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 1.9 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 7.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 5.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 5.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 5.1 | GO:0032094 | response to food(GO:0032094) |
0.3 | 2.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 8.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 6.6 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.3 | 5.6 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.3 | 1.9 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.3 | 5.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 6.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 3.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 1.9 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 19.0 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 3.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 1.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.2 | 2.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 3.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 3.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 3.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 4.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 8.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 6.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 3.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 1.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 8.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 8.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 4.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 4.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 2.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 3.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 8.3 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 4.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 8.9 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.2 | 7.5 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.2 | 3.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 5.2 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 7.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 2.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 6.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 5.4 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 2.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 11.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 3.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 2.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 5.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 3.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 2.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 4.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 2.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.7 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 2.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 1.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 2.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 7.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 2.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 1.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.6 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 3.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 6.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 21.6 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.1 | 1.2 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 5.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 1.2 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
0.1 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 2.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 1.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 5.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 4.6 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
0.1 | 0.9 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 1.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.5 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.6 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 1.5 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.1 | 0.6 | GO:0021544 | grooming behavior(GO:0007625) subpallium development(GO:0021544) striatum development(GO:0021756) |
0.1 | 2.6 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.0 | 3.1 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 2.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 1.8 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 1.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 1.7 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 1.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 2.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 1.0 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 4.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 1.9 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.4 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 1.2 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 1.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 6.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 3.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 3.2 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 77.3 | GO:0097386 | glial cell projection(GO:0097386) |
3.7 | 29.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
3.0 | 45.4 | GO:0000124 | SAGA complex(GO:0000124) |
2.7 | 26.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.2 | 22.0 | GO:0070938 | dystroglycan complex(GO:0016011) contractile ring(GO:0070938) |
1.9 | 5.7 | GO:0031251 | PAN complex(GO:0031251) |
1.8 | 3.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.7 | 5.1 | GO:0060187 | cell pole(GO:0060187) |
1.7 | 11.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.5 | 7.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.5 | 10.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.4 | 22.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.3 | 6.4 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
1.3 | 7.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.2 | 4.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.1 | 10.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
1.0 | 4.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.0 | 3.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.0 | 14.5 | GO:0001741 | XY body(GO:0001741) |
0.9 | 5.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.9 | 25.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.9 | 2.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.9 | 7.0 | GO:0014802 | terminal cisterna(GO:0014802) |
0.8 | 33.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.8 | 3.3 | GO:0055087 | Ski complex(GO:0055087) |
0.8 | 5.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 11.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 5.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 4.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.6 | 7.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 13.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.6 | 5.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.6 | 25.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 6.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 32.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 3.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 4.2 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 1.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.4 | 28.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 4.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 20.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 3.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 4.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 5.7 | GO:0032059 | bleb(GO:0032059) |
0.3 | 15.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 3.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 8.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 2.0 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 2.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 32.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 13.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 4.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 7.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 2.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 6.3 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 12.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 2.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 9.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 2.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 5.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 48.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 3.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 14.4 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 0.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 2.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 3.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 1.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 2.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 4.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 4.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 4.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 10.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 7.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 2.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 4.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 10.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 3.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 9.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 5.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 4.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 3.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 3.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 23.1 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 20.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 9.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 6.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 4.3 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 4.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 2.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 2.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 2.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 86.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 1.3 | GO:0016459 | myosin complex(GO:0016459) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.3 | 77.3 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
11.0 | 54.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
3.7 | 22.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
3.4 | 10.3 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
2.7 | 27.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
2.5 | 7.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.5 | 12.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.3 | 11.6 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
2.0 | 5.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.9 | 30.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.9 | 5.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.9 | 5.6 | GO:0070888 | E-box binding(GO:0070888) |
1.8 | 12.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.8 | 5.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.7 | 5.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.7 | 5.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.7 | 71.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.7 | 6.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.6 | 6.5 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
1.6 | 8.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
1.3 | 8.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.3 | 6.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.3 | 5.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.3 | 24.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.3 | 3.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.2 | 3.7 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
1.2 | 8.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.2 | 9.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.2 | 3.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.1 | 12.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.1 | 5.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.1 | 4.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.1 | 17.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.1 | 6.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.0 | 20.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 5.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.9 | 4.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.9 | 6.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.9 | 3.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 5.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.9 | 5.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.8 | 4.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.8 | 5.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 2.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.7 | 11.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.7 | 47.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.7 | 5.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 6.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 5.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 5.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 4.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.7 | 7.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 4.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 4.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 5.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 3.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 3.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.6 | 6.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 26.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.6 | 4.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 7.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 12.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 4.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 2.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.6 | 5.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 7.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 2.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 3.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.5 | 2.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.5 | 5.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 2.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 7.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 6.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 3.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 3.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 2.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 4.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 9.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 4.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 19.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 15.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 4.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 5.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 5.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 27.5 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 18.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 4.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 35.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 4.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 7.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 4.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 9.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 7.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 4.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 15.2 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 1.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 4.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 15.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 2.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 4.5 | GO:0008603 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 5.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 6.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 4.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 14.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 3.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 2.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.2 | 2.7 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 6.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 5.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 5.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 3.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 5.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 4.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 21.4 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 6.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 3.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 1.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 9.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 19.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 4.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 5.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 2.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 10.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 2.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 3.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 4.8 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 2.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 3.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 2.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 14.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 6.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 3.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 3.6 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 8.2 | GO:0015075 | ion transmembrane transporter activity(GO:0015075) |
0.1 | 6.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 4.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 6.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 4.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 15.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 3.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 6.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 3.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 3.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 1.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 2.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 3.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.0 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 3.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 1.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 4.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.8 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 5.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 21.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 33.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 76.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 7.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 43.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 22.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 6.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 6.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 21.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 4.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 21.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 12.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 7.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 12.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 8.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 6.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 9.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 17.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 6.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 7.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 10.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 12.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 5.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 7.2 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 5.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 4.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 3.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 8.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 6.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 5.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 5.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 29.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 10.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 38.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 5.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 2.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 4.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 2.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 72.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.4 | 28.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.2 | 25.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 2.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 7.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 17.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 14.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 8.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 5.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 10.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 11.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 27.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 15.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 6.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 4.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 4.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.4 | 6.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 6.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 9.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 6.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 9.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 3.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 18.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 5.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 6.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 14.4 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.3 | 8.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 7.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 5.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 37.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 4.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 3.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 5.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 8.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 3.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 7.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 5.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 8.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 7.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 8.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 5.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 5.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 4.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 5.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 4.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 10.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 4.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 4.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 4.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 6.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 2.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 17.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 6.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 3.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 4.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |